The Democratic Republic of the Congo (DRC) yesterday announced a new Ebola case, its first since September, which involves a woman who died from her infection in Butembo, one of the main hot spots in the country's 10th outbreak that was centered in North Kivu and Ituri provinces.
Five barriers to better antibiotic decision-making at hospital discharge emerged after John Hopkins University School of Medicine researchers interviewed healthcare workers and discharged patients.
Two new studies highlight the threat posed by the multidrug-resistant yeast Candida auris to hospitalized COVID-19 patients.
In a study today in the Journal of the Pediatric Infectious Diseases Society, US and Colombian researchers report that nearly one-third of the pediatric invasive Candida bloodstream infections (BSIs) analyzed at two Colombian pediatric hospitals were caused by Candida auris.
The World Health Organization (WHO) Ebola emergency committee that met today to review the outbreak situation in the Democratic Republic of the Congo (DRC) recommended continuing the public health emergency of international concern under International Health Regulations.
Candida auris formed biofilms that were 10 times as dense as those formed by C albicans.
The authors say the finding is concerning and emphasize the role of repeat susceptibility tests.
The Agency for Healthcare Research and Quality (AHRQ) has released a new toolkit to improve antibiotic use in acute care hospitals.
Resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths a year in the United States, a new report says.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
